Litcius/Paper detail

FDA approves teplizumab: a milestone in type 1 diabetes

James S Hirsch

2022The Lancet Diabetes & Endocrinology51 citationsDOI

Topics & Concepts

MedicineMilestoneType 2 diabetesMEDLINEDiabetes mellitusIntensive care medicineEndocrinologyPolitical scienceLawArchaeologyHistoryDiabetes Management and ResearchDiabetes and associated disorders
FDA approves teplizumab: a milestone in type 1 diabetes | Litcius